Here are eight takeaways from the report:
1. The company saw net sales of $1.93 billion. That’s a 2 percent increase compared to the same time last year.
2. Diluted earnings per share were $1.16 for the third quarter, a decrease of 44.2 percent from the same period last year. Adjusted diluted earnings per share were $1.81, an increase of 2.3 percent compared to the third quarter in 2019.
3. Net sales from knee products were $402.6 million in the Americas, a 0.9 percent increase compared to last year. Overall, knee products saw net sales of $648.7 million in the third quarter, which is a 0.5 percent drop from the same period last year.
4. Hip product net sales in the Americas were $268.6 million, an uptick of 7.9 percent compared to the third quarter in 2019. A global increase for hips was 5.4 percent, leaving Zimmer with $484.1 million in overall net sales for that category in the third quarter.
5. The sports medicine, extremities and trauma category saw a 3.3 percent year-over-year increase in net sales, ending the second quarter with $359.9 million. Net sales for dental, spine, and craniomaxillofacial and thoracic products were up about 7.3 percent at $295.5 million.
6. Zimmer Biomet paid $49.6 million in dividends and declared a dividend of $0.24 per share in the third quarter.
7. The company refinanced $1.5 billion in debt that came due April 1, renegotiated the terms of its $1.5 billion revolver and secured an additional $1 billion credit facility.
8. The company saw some recovery in elective procedures during the third quarter, but because uncertainty remains around the scope and duration of the COVID-19 pandemic, it did not provide fourth-quarter financial guidance.
More articles on devices:
Orthopedic surgery has 3rd highest gender wage gap among medical specialties, report finds
A timeline of Medtronic’s 7 deals so far in 2020
Robots will never replace surgeons, but can prove useful partners: 3 spine surgeons weigh in
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
